Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 13, 2021

SELL
$10.88 - $17.05 $45,271 - $70,945
-4,161 Reduced 4.91%
80,650 $1.01 Million
Q2 2020

Aug 13, 2020

SELL
$6.21 - $11.83 $90,100 - $171,641
-14,509 Reduced 14.61%
84,811 $760,000
Q1 2020

May 13, 2020

SELL
$5.05 - $8.85 $25,088 - $43,966
-4,968 Reduced 4.76%
99,320 $633,000
Q3 2019

Nov 13, 2019

SELL
$9.05 - $12.22 $103,631 - $139,931
-11,451 Reduced 9.89%
104,288 $944,000
Q2 2019

Aug 13, 2019

SELL
$8.75 - $13.03 $119,288 - $177,637
-13,633 Reduced 10.54%
115,739 $1.25 Million
Q1 2019

May 13, 2019

SELL
$7.72 - $12.81 $134,080 - $222,484
-17,368 Reduced 11.84%
129,372 $1.23 Million
Q4 2018

Feb 12, 2019

SELL
$9.51 - $16.6 $915,432 - $1.6 Million
-96,260 Reduced 39.61%
146,740 $1.69 Million
Q2 2018

Aug 13, 2018

BUY
$13.9 - $19.8 $3.38 Million - $4.81 Million
243,000 New
243,000 $3.45 Million

Others Institutions Holding SGMO

About SANGAMO THERAPEUTICS, INC


  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $178M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Ws Management Lllp Portfolio

Follow Ws Management Lllp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ws Management Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Ws Management Lllp with notifications on news.